EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibiotic resistant bacteria survive treatment by doubling while shrinking

Adrian Campey, Urszula Łapińska, Remy Chait, Krasimira Tsaneva-Atanasova, Stefano Pagliara iD

mBio · 2024

DOI: 10.1128/mbio.02375-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Adrian Campey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Living Systems Institute and Biosciences, University of Exeter, Exeter, Devon, United Kingdom. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Ciprofloxacin, Escherichia coli, Mutation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI | Biotechnology and Biological Sciences Research Council (BBSRC), UKRI | Engineering and Physical Sciences Research Council (EPSRC), UKRI | Medical Research Council (MRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many antibiotics that are used in healthcare, farming, and aquaculture end up in environments with different spatial structures that might promote heterogeneity in the emergence of antibiotic resistance. However, the experimental evolution of microbes at sub-inhibitory concentrations of antibiotics has been mainly carried out at the population level which does not allow capturing single-cell responses to antibiotics. Here, we investigate and compare the emergence of resistance to ciprofloxacin in Escherichia coli in well-mixed and structured environments using experimental evolution, genomics, and microfluidics-based time-lapse microscopy. We discover that resistance to ciprofloxacin and cross-resistance to other antibiotics is stronger in the well-mixed environment due to the emergence of target mutations, whereas efflux regulator mutations emerge in the structured environment. The latter mutants also harbor sub-populations of persisters that survive high concentrations of ciprofloxacin that inhibit bacterial growth at the population level. In contrast, genetically resistant bacteria that display target mutations also survive high concentrations of ciprofloxacin that inhibit their growth via population-level antibiotic tolerance. These resistant and tolerant bacteria keep doubling while shrinking in size in the presence of ciprofloxacin and regain their original size after antibiotic removal, which constitutes a newly discovered phenotypic response. This new knowledge sheds light on the diversity of strategies employed by bacteria to survive antibiotics and poses a stepping stone for understanding the link between mutations at the population level and phenotypic single-cell responses. IMPORTANCE The evolution of antimicrobial resistance poses a pressing challenge to global health with an estimated 5 million deaths associated with antimicrobial resistance every year globally. Here, we investigate the diversity of strategies employed by bacteria to survive antibiotics. We discovered that bacteria evolve genetic resistance to antibiotics while simultaneously displaying tolerance to very high doses of antibiotics by doubling while shrinking in size.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsCiprofloxacinEscherichia coliMutationDrug Resistance, BacterialMicrobial Sensitivity TestsMicrobial Viability

Stichwörter der Autor:innen

antibiotic toleranceantimicrobial resistanceeffluxenvironmental structureevolutionmicrofluidicsmutationspersisterssequencingsingle-cell analysis

Substanzen

Anti-Bacterial AgentsCiprofloxacin

Autor:innen und Institutionen

  • Living Systems Institute and Biosciences, University of Exeter, Exeter, Devon, United Kingdom.
  • EPSRC Hub for Quantitative Modelling in Healthcare, University of Exeter, Exeter, Devon, United Kingdom.

ORCID-Profile: Stefano Pagliara

Förderung

  • UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)
  • UKRI | Engineering and Physical Sciences Research Council (EPSRC)
  • UKRI | Medical Research Council (MRC)

Zitieren

APA

Campey, A., Łapińska, U., Chait, R., Tsaneva-Atanasova, K., & Pagliara, S. (2024). Antibiotic resistant bacteria survive treatment by doubling while shrinking. mBio. https://doi.org/10.1128/mbio.02375-24

Vancouver

Campey A, Łapińska U, Chait R, Tsaneva-Atanasova K, Pagliara S. Antibiotic resistant bacteria survive treatment by doubling while shrinking. mBio. 2024. doi:10.1128/mbio.02375-24

BibTeX
@article{Campey2024,
  author = {Campey, Adrian and Łapińska, Urszula and Chait, Remy and Tsaneva-Atanasova, Krasimira and Pagliara, Stefano},
  title = {Antibiotic resistant bacteria survive treatment by doubling while shrinking},
  journal = {mBio},
  year = {2024},
  doi = {10.1128/mbio.02375-24}
}
Kostenlos starten →